Unravelling the molecular mechanisms underlying complement dysregulation by nephritic factors in C3G and IC-MPGN

Roberta Donadelli; Patrizia Pulieri; Rossella Piras; Paraskevas Iatropoulos; Elisabetta Valoti; Ariela Benigni; Giuseppe Remuzzi; Marina Noris

doi:10.1016/j.molimm.2018.06.055

Related publications

Article2018

Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN

Roberta Donadelli, Patrizia Pulieri, Rossella Piras, Paraskevas Iatropoulos, Elisabetta Valoti, Ariela Benigni, Giuseppe Remuzzi, Marina Noris

Article2017

Unravelling the pathophysiology of C3G/IC-MPGN and how to predict disease progression and orient therapies

Paraskevas Iatropoulos, Erica Daina, Manuela Curreri, Rossella Piras, Elisabetta Valoti, Caterina Mele, Elena Bresin, Sara Gamba, Marta Alberti, Matteo Breno, Serena Bettoni, Ettore Sabadini, Luisa Murer, Marina Vivarelli, Marina Noris, Giuseppe Remuzzi

Article2022

POS-048 PHASE 3, RANDOMIZED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PEGCETACOPLAN IN TREATMENT OF C3G OR IC-MPGN

Giuseppe Remuzzi, Bradley P. Dixon, Fádi Fakhouri, Matthew C. Pickering, Terry Cook, D. Kavanagh, Patrick D. Walker, Christoph Licht, Gerald B. Appel, Marina Vivarelli, Zhuojing Zhang, L. Li, Hetal S. Kocinsky

Article2025

#288 Pegcetacoplan demonstrates clinically significant responses in C3G and primary (idiopathic) IC-MPGN Patients with or without concomitant immunosuppression in VALIANT

David Kavanagh, Andrew S. Bomback, Gema Ariceta, Antonio Mastrangelo, Carla Nester, Giuseppe Remuzzi, Marina Vivarelli, Zhongshen Wang, Johan Szamosi, Dima Decker, Lenny Gallardo, Fádi Fakhouri

Article2025

#3391 Pegcetacoplan treatment appears to halt disease progression in C3G and primary (idiopathic) IC-MPGN patients: results from the phase 3 VALIANT study

Daniel P. Gale, Andrew S. Bomback, Christoph Licht, Carla Nester, Matthew C. Pickering, Giuseppe Remuzzi, Nicole C. A. J. van de Kar, Zhongshen Wang, Johan Szamosi, Dima Decker, Luis Fernando Barba-Gallardo, Fádi Fakhouri